Article
Silencing of the glypican-3 gene affects the biological behavior of human hepatocellular carcinoma cells
26 Sept 2014
Abstract excerpt
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death in the world. The gene glypican-3 (GPC3) is reported to be a potential therapeutic target for HCC. In this study, we use RNA interference with lentiviral vectors to explore the effect of GPC3 silencing on the biological behavior of HCC cells and the potential role of the GPC3 protein in the activation of epithelial-mesenchymal transition...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
